Professor Jon Marsden

Plymouth University
Professorship and Chair in Rehabilitation

Jonathan graduated with a BSc (Hons) 1st Class in Physiotherapy from Manchester University in 1991 and graduated with an MSc (Distinction) in Neurological Science, from University College in London. Where he also went on to receive his PhD in Clinical Medicine, 2000.

Jonathan currently teaches on the MSc in Neurological Rehabilitation at the School of Health Professions. He is the lead for the "Cognition, perception and behaviour" module and contribute "sensorimotor control in neurological practice" and "pathomechanics and rehabilitation of gait and balance". He also contributes to the undergraduate physiotherapy program Neurological Physiotherapy module.

His research interests and experience are in the field of neurorehabilitation and human motor physiology. He is currently investigating the pathophysiology and rehabilitation of balance and gait disorders after central and peripheral neurological lesions in adult and paediatric populations.

dont miss

Rehabilitation of balance and gait in cerebellar disorders

This talk will provide an overview of how cerebellar dysfunction affects balance, gait and falls. It will summarise recent clinical trials of rehabilitation and pharmacological interventions that target balance and gait and provide a practical summary of what constitutes current best practice.

EVEN MORE SEMINARS

  • Amanda Denton: Speaking at the European Neurological Convention

    Amanda Denton
    Plymouth University

    Professional Development CPD Café

  • Nick Thomas: Speaking at the European Neurological Convention

    Nick Thomas
    London Neurosurgery Partnership

    Endoscopic Endonasal Approaches to the Skull Base- further advances

  • Armin Schnürer: Speaking at the European Neurological Convention

    Armin Schnürer
    g.tec medical engineering

    Brain-Computer Interfaces (BCI) for stroke rehabilitation and consciousness assessment

  • Tina Soulis: Speaking at the European Neurological Convention

    Tina Soulis
    Neuroscience Trials Australia

    Strategies in CNS Drug and Device Development: The Australian Advantage

  • Heather Campbell: Speaking at the European Neurological Convention

    Heather Campbell
    Guys & St Thomas’ NHS Foundation trust

    Navigating pathways for “invisible patients” in South East London